Adi Mor
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Adi Mor is the founder of Chemomab Therapeutics Ltd. since 2011, holding the title of CEO, Director & Chief Scientific Officer since 2023.
Dr. Mor was the founder of Chemomab Ltd. since 2011, holding the title of Director, Chief Executive & Scientific Officer from 2011 to 2021.
Dr. Mor holds a doctorate from Tel-Aviv University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 10.346.160 ( 2,5% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Algemeen Directeur | 01-06-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Algemeen Directeur | 16-03-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Ltd.
Chemomab Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops therapeutics for fibro-inflammatory diseases | Commercial Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau